Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation.

Baturina, Olga; Andreev, Denis; Fedina, Ludmila; Mirzaev, Karin; Ivashchenko, Dmitriy; Ryzhikova, Kristina; Grishina, Elena; Bochkov, Pavel; Shevchenko, Roman; Sychev, Dmitriy

Baturina, Olga; Andreev, Denis; Fedina, Ludmila; Mirzaev, Karin; Ivashchenko, Dmitriy; Ryzhikova, Kristina; Grishina, Elena; Bochkov, Pavel; Shevchenko, Roman; Sychev, Dmitriy.

Afiliación

Baturina O; Department of Preventive and Emergency Cardiology, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Andreev D; Department of Preventive and Emergency Cardiology, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Fedina L; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Mirzaev K; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Ivashchenko D; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Ryzhikova K; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Grishina E; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Bochkov P; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Shevchenko R; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Sychev D; Department of Clinical Pharmacology and Therapy, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.

Pharmacology ; 107(3-4): 216-226, 2022.

Article en En | MEDLINE | ID: mdl-35073541

Asunto(s)

Síndrome Coronario Agudo; Fibrilación Atrial; Intervención Coronaria Percutánea; Síndrome Coronario Agudo/tratamiento farmacológico; Síndrome Coronario Agudo/genética; Arildialquilfosfatasa/genética; Arildialquilfosfatasa/uso terapéutico; Fibrilación Atrial/inducido químicamente; Fibrilación Atrial/tratamiento farmacológico; Fibrilación Atrial/genética; Clopidogrel/efectos adversos; Citocromo P-450 CYP2C19/genética; Humanos; Intervención Coronaria Percutánea/efectos adversos; Inhibidores de Agregación Plaquetaria/efectos adversos; Estudios Prospectivos; Receptores de Superficie Celular/genética; Receptores de Superficie Celular/uso terapéutico; Ticlopidina/efectos adversos; Resultado del Tratamiento

Palabras clave

Acute coronary syndrome; Clopidogrel; Personalized medicine; Pharmacogenetics; Platelet aggregation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Síndrome Coronario Agudo / Intervención Coronaria Percutánea Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharmacology Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google